$OPRT
Oportun Financial Corp Stock $oprt

$oprt Overview Financials Valuation SEC Filings Company Website

2024 Q1 Form 10-K Financial Statement

#000153871624000032 Filed on March 15, 2024

Income Statement

Concept	2024 Q1	2023 Q4	2023
Revenue	$250.5M	$72.10M	$1.057B
YoY Change	-3.48%	-68.15%	10.96%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$11.78M	$129.4M	$72.39M
YoY Change	-38.54%	-61.23%	23.02%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$1.100M	$13.78M	$4.300M
YoY Change	-15.38%	-1277.03%	-17.31%
% of Gross Profit
Operating Expenses	$109.6M	$129.4M	$534.3M
YoY Change	-25.08%	-61.23%	808.12%
Operating Profit
YoY Change
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income	-$30.48M	-$57.28M	-$253.7M
YoY Change	-78.47%	623.22%	236.92%
Income Tax	-$4.000M	-$15.46M	-$73.70M
% Of Pretax Income
Net Earnings	-$26.44M	-$41.82M	-$180.0M
YoY Change	-74.1%	396.72%	131.47%
Net Earnings / Revenue	-10.56%	-58.01%	-17.03%
Basic Earnings Per Share	-$0.68		-$4.88
Diluted Earnings Per Share	-$0.68	-$1.09	-$4.88
COMMON SHARES
Basic Shares Outstanding	34.56M shares	34.23M shares	36.88M shares
Diluted Shares Outstanding	38.90M shares		36.88M shares

Balance Sheet

Concept	2024 Q1	2023 Q4	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments	$69.20M	$91.19M	$91.19M
YoY Change	-6.59%	-7.72%	-7.72%
Cash & Equivalents	$69.20M	$91.19M	$91.19M
Short-Term Investments
Other Short-Term Assets	$15.60M	$15.76M	$15.76M
YoY Change	-89.48%	-87.81%	-87.81%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$84.80M	$106.9M	$106.9M
YoY Change	-97.41%	-96.87%	-96.87%
LONG-TERM ASSETS
Property, Plant & Equipment	$6.017M	$6.991M	$28.10M
YoY Change	-39.57%	-33.57%	-31.42%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$180.3M	$163.0M	$163.0M
YoY Change	435.51%	739.96%	739.96%
Total Long-Term Assets	$3.193B	$3.305B	$3.305B
YoY Change	1305.69%	1536.39%	1536.35%
TOTAL ASSETS
Total Short-Term Assets	$84.80M	$106.9M	$106.9M
Total Long-Term Assets	$3.193B	$3.305B	$3.305B
Total Assets	$3.278B	$3.412B	$3.412B
YoY Change	-6.41%	-5.58%	-5.58%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$6.531M	$5.288M	$5.288M
YoY Change	-6.57%	-45.32%	-45.32%
Accrued Expenses	$70.03M	$76.94M	$76.94M
YoY Change	36.88%	63.22%	63.22%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$83.69M	$89.37M	$89.37M
YoY Change	7.32%	-43.02%	-43.02%
LONG-TERM LIABILITIES
Long-Term Debt	$2.805B	$2.910B	$2.910B
YoY Change	-4.46%	2.06%	2.06%
Other Long-Term Liabilities	$6.941M	$7.946M	$7.946M
YoY Change	-105.19%	-106.92%	-106.92%
Total Long-Term Liabilities	$2.812B	$2.918B	$2.918B
YoY Change	0.35%	6.63%	6.63%
TOTAL LIABILITIES
Total Short-Term Liabilities	$83.69M	$89.37M	$89.37M
Total Long-Term Liabilities	$2.812B	$2.918B	$2.918B
Total Liabilities	$2.896B	$3.007B	$3.007B
YoY Change	-4.94%	-1.91%	-1.91%
SHAREHOLDERS EQUITY
Retained Earnings	-$200.3M	-$173.8M
YoY Change	108.66%	-2949.05%
Common Stock	$588.6M	$584.6M
YoY Change	5.39%	6.71%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$382.0M	$404.4M	$404.4M
YoY Change
Total Liabilities & Shareholders Equity	$3.278B	$3.412B	$3.412B
YoY Change	-6.41%	-5.58%	-5.58%

Cashflow Statement

Concept	2024 Q1	2023 Q4	2023
OPERATING ACTIVITIES
Net Income	-$26.44M	-$41.82M	-$180.0M
YoY Change	-74.1%	396.72%	131.47%
Depreciation, Depletion And Amortization	$1.100M	$13.78M	$4.300M
YoY Change	-15.38%	-1277.03%	-17.31%
Cash From Operating Activities	$85.88M	$106.3M	$392.8M
YoY Change	11.81%	410.37%	58.45%
INVESTING ACTIVITIES
Capital Expenditures	$3.221M	$6.316M	$32.70M
YoY Change	-74.26%	-56.83%	445.5%
Acquisitions
YoY Change
Other Investing Activities	$124.0K	-$90.50M	$1.442M
YoY Change	-83.9%	-508.01%	-100.12%
Cash From Investing Activities	$36.46M	-$96.81M	-$286.2M
YoY Change	-191.96%	-536.49%	-75.57%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-$131.8M	-3.127M	-$104.4M
YoY Change	237.43%	-98.75%	-111.17%
NET CHANGE
Cash From Operating Activities	$85.88M	106.3M	$392.8M
Cash From Investing Activities	$36.46M	-96.81M	-$286.2M
Cash From Financing Activities	-$131.8M	-3.127M	-$104.4M
Net Change In Cash	-$9.463M	6.371M	$2.199M
YoY Change	399.1%	-103.08%	-79.75%
FREE CASH FLOW
Cash From Operating Activities	$85.88M	$106.3M	$392.8M
Capital Expenditures	$3.221M	$6.316M	$32.70M
Free Cash Flow	$82.66M	$99.99M	$360.1M
YoY Change	28.55%	1512.56%	48.86%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	-4000000	usd
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001538716
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023Q1	us-gaap	Impairment Of Intangible Asset Finite Lived Statement Of Income Or Comprehensive Income Extensible Enumeration ImpairmentOfIntangibleAssetFiniteLivedStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration	http://fasb.org/us-gaap/2023#SellingGeneralAndAdministrativeExpense
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Entity File Number EntityFileNumber	001-39050
CY2023	dei	Entity Registrant Name EntityRegistrantName	OPORTUN FINANCIAL CORPORATION
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2023	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	45-3361983
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	2 Circle Star Way
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	San Carlos,
CY2023	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	94070
CY2023	dei	City Area Code CityAreaCode	650
CY2023	dei	Local Phone Number LocalPhoneNumber	810-8823
CY2023	dei	Security12b Title Security12bTitle	Common Stock, $0.0001 par value per share
CY2023	dei	Trading Symbol TradingSymbol	OPRT
CY2023	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Small Business EntitySmallBusiness	true
CY2023	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	true
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Public Float EntityPublicFloat	137700000	usd
CY2024Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	34557486	shares
CY2023	dei	Auditor Firm AuditorFirmId	34
CY2023	dei	Auditor Name AuditorName	Deloitte & Touche LLP
CY2023	dei	Auditor Location AuditorLocation	San Francisco, CA
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	91187000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	98817000	usd
CY2023Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	114829000	usd
CY2022Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	105000000	usd
CY2023Q4	oprt	Loansand Leases Receivable Grossat Fair Value LoansandLeasesReceivableGrossatFairValue	2962352000	usd
CY2022Q4	oprt	Loansand Leases Receivable Grossat Fair Value LoansandLeasesReceivableGrossatFairValue	3175449000	usd
CY2023Q4	oprt	Capitalized Software And Other Intangibles Net CapitalizedSoftwareAndOtherIntangiblesNet	114735000	usd
CY2022Q4	oprt	Capitalized Software And Other Intangibles Net CapitalizedSoftwareAndOtherIntangiblesNet	139801000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	21105000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	30448000	usd
CY2023Q4	us-gaap	Other Assets OtherAssets	107680000	usd
CY2022Q4	us-gaap	Other Assets OtherAssets	64180000	usd
CY2023Q4	us-gaap	Assets Assets	3411888000	usd
CY2022Q4	us-gaap	Assets Assets	3613695000	usd
CY2023Q4	us-gaap	Warehouse Agreement Borrowings WarehouseAgreementBorrowings	289951000	usd
CY2022Q4	us-gaap	Warehouse Agreement Borrowings WarehouseAgreementBorrowings	317568000	usd
CY2023Q4	oprt	Secured Debt Fair Value SecuredDebtFairValue	1780005000	usd
CY2022Q4	oprt	Secured Debt Fair Value SecuredDebtFairValue	2387674000	usd
CY2023Q4	oprt	Secured Debt At Amortized Cost SecuredDebtAtAmortizedCost	581468000	usd
CY2022Q4	oprt	Secured Debt At Amortized Cost SecuredDebtAtAmortizedCost	0	usd
CY2023Q4	oprt	Acquisition And Corporate Financing Debt AcquisitionAndCorporateFinancingDebt	258746000	usd
CY2022Q4	oprt	Acquisition And Corporate Financing Debt AcquisitionAndCorporateFinancingDebt	222879000	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	28376000	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	37947000	usd
CY2023Q4	us-gaap	Other Liabilities OtherLiabilities	68938000	usd
CY2022Q4	us-gaap	Other Liabilities OtherLiabilities	100028000	usd
CY2023Q4	us-gaap	Liabilities Liabilities	3007484000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	3066096000	usd
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1000000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1000000000	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	34741076	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	34469053	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	33626630	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	33354607	shares
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	7000	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	7000	usd
CY2023Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	584555000	usd
CY2022Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	547799000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-173849000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	6102000	usd
CY2023Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	272023	shares
CY2022Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	272023	shares
CY2023Q4	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	6309000	usd
CY2022Q4	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	6309000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	404404000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	547599000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	3411888000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	3613695000	usd
CY2023	us-gaap	Interest And Fee Income Loans Consumer InterestAndFeeIncomeLoansConsumer	963496000	usd
CY2022	us-gaap	Interest And Fee Income Loans Consumer InterestAndFeeIncomeLoansConsumer	876114000	usd
CY2023	us-gaap	Noninterest Income Other Operating Income NoninterestIncomeOtherOperatingIncome	93423000	usd
CY2022	us-gaap	Noninterest Income Other Operating Income NoninterestIncomeOtherOperatingIncome	76431000	usd
CY2022	us-gaap	Revenues Revenues	952545000	usd
CY2023	us-gaap	Debt Securities Realized Gain Loss DebtSecuritiesRealizedGainLoss	-596839000	usd
CY2023	us-gaap	Revenues Net Of Interest Expense RevenuesNetOfInterestExpense	280666000	usd
CY2022	us-gaap	Revenues Net Of Interest Expense RevenuesNetOfInterestExpense	640657000	usd
CY2023	us-gaap	Communications Information Technology And Occupancy CommunicationsInformationTechnologyAndOccupancy	219406000	usd
CY2022	us-gaap	Communications Information Technology And Occupancy CommunicationsInformationTechnologyAndOccupancy	216120000	usd
CY2023	us-gaap	Business Development BusinessDevelopment	75284000	usd
CY2022	us-gaap	Business Development BusinessDevelopment	110033000	usd
CY2023	us-gaap	Labor And Related Expense LaborAndRelatedExpense	121843000	usd
CY2022	us-gaap	Labor And Related Expense LaborAndRelatedExpense	154850000	usd
CY2023	us-gaap	Professional Fees ProfessionalFees	45401000	usd
CY2022	us-gaap	Professional Fees ProfessionalFees	67630000	usd
CY2023	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	72385000	usd
CY2022	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	58838000	usd
CY2023	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
CY2022	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	108472000	usd
CY2023	us-gaap	Operating Expenses OperatingExpenses	534319000	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	715943000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-253653000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-75286000	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-73702000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2458000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-179951000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-77744000	usd
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-179951000	usd
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-179951000	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-77744000	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-77744000	usd
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-4.88
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-2.37
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-4.88
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-2.37
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	36875950	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	32825772	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	36875950	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	32825772	shares
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	547599000	usd
CY2023	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	-46000	usd
CY2023	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	20024000	usd
CY2023	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	-2653000	usd
CY2023	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	19431000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-179951000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	404404000	usd
CY2022	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	-4635000	usd
CY2022	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	28000	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	30125000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-77744000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	547599000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-77744000	usd
CY2023	us-gaap	Depreciation Amortization And Accretion Net DepreciationAmortizationAndAccretionNet	54885000	usd
CY2022	us-gaap	Depreciation Amortization And Accretion Net DepreciationAmortizationAndAccretionNet	47533000	usd
CY2023	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
CY2022	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	108472000	usd
CY2023	us-gaap	Debt Securities Realized Gain Loss DebtSecuritiesRealizedGainLoss	-596839000	usd
CY2022	us-gaap	Debt Securities Realized Gain Loss DebtSecuritiesRealizedGainLoss	-218842000	usd
CY2023	us-gaap	Amortization Of Deferred Loan Origination Fees Net AmortizationOfDeferredLoanOriginationFeesNet	23360000	usd
CY2022	us-gaap	Amortization Of Deferred Loan Origination Fees Net AmortizationOfDeferredLoanOriginationFeesNet	26845000	usd
CY2023	us-gaap	Gain Loss On Sales Of Consumer Loans GainLossOnSalesOfConsumerLoans	8481000	usd
CY2022	us-gaap	Gain Loss On Sales Of Consumer Loans GainLossOnSalesOfConsumerLoans	5703000	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	18593000	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	27620000	usd
CY2023	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	53195000	usd
CY2022	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-30336000	usd
CY2023	us-gaap	Payments For Origination And Purchases Of Loans Held For Sale PaymentsForOriginationAndPurchasesOfLoansHeldForSale	56603000	usd
CY2022	us-gaap	Payments For Origination And Purchases Of Loans Held For Sale PaymentsForOriginationAndPurchasesOfLoansHeldForSale	52742000	usd
CY2023	us-gaap	Proceeds From Sale Of Other Loans Held For Sale ProceedsFromSaleOfOtherLoansHeldForSale	65088000	usd
CY2022	us-gaap	Proceeds From Sale Of Other Loans Held For Sale ProceedsFromSaleOfOtherLoansHeldForSale	58844000	usd
CY2023	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	21050000	usd
CY2022	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	80738000	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	392765000	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	247875000	usd
CY2023	us-gaap	Payments To Acquire Loans Held For Investment PaymentsToAcquireLoansHeldForInvestment	1580134000	usd
CY2022	us-gaap	Payments To Acquire Loans Held For Investment PaymentsToAcquireLoansHeldForInvestment	2762828000	usd
CY2023	us-gaap	Proceeds From Sale Of Loans Held For Investment ProceedsFromSaleOfLoansHeldForInvestment	4055000	usd
CY2022	us-gaap	Proceeds From Sale Of Loans Held For Investment ProceedsFromSaleOfLoansHeldForInvestment	249271000	usd
CY2023	us-gaap	Proceeds From Collection Of Finance Receivables ProceedsFromCollectionOfFinanceReceivables	1322601000	usd
CY2022	us-gaap	Proceeds From Collection Of Finance Receivables ProceedsFromCollectionOfFinanceReceivables	1396896000	usd
CY2023	us-gaap	Payments For Software PaymentsForSoftware	31261000	usd
CY2022	us-gaap	Payments For Software PaymentsForSoftware	48892000	usd
CY2023	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	1442000	usd
CY2022	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	5995000	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-286181000	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1171548000	usd
CY2023	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	245700000	usd
CY2022	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	1972000000	usd
CY2023	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	274751000	usd
CY2022	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	2050000000	usd
CY2023	us-gaap	Proceeds From Issuance Of Secured Debt ProceedsFromIssuanceOfSecuredDebt	0	usd
CY2022	us-gaap	Proceeds From Issuance Of Secured Debt ProceedsFromIssuanceOfSecuredDebt	1262059000	usd
CY2023	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	707619000	usd
CY2022	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	232675000	usd
CY2023	oprt	Proceeds From Issuance Of Asset Backed Borowings At Amortized Cost ProceedsFromIssuanceOfAssetBackedBorowingsAtAmortizedCost	626405000	usd
CY2022	oprt	Proceeds From Issuance Of Asset Backed Borowings At Amortized Cost ProceedsFromIssuanceOfAssetBackedBorowingsAtAmortizedCost	0	usd
CY2023	oprt	Repayments Of Asset Backed Notes At Amortized Cost RepaymentsOfAssetBackedNotesAtAmortizedCost	33615000	usd
CY2022	oprt	Repayments Of Asset Backed Notes At Amortized Cost RepaymentsOfAssetBackedNotesAtAmortizedCost	0	usd
CY2023	oprt	Proceeds From Issuance Of Acquisition And Corporate Financing Debt ProceedsFromIssuanceOfAcquisitionAndCorporateFinancingDebt	73355000	usd
CY2022	oprt	Proceeds From Issuance Of Acquisition And Corporate Financing Debt ProceedsFromIssuanceOfAcquisitionAndCorporateFinancingDebt	0	usd
CY2023	oprt	Repayments Of Acquisition And Corporate Financing Debt RepaymentsOfAcquisitionAndCorporateFinancingDebt	28442000	usd
CY2022	oprt	Repayments Of Acquisition And Corporate Financing Debt RepaymentsOfAcquisitionAndCorporateFinancingDebt	0	usd
CY2023	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	2719000	usd
CY2022	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	8189000	usd
CY2023	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-2699000	usd
CY2022	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-8665000	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-104385000	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	934530000	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	2199000	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	10857000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	203817000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	192960000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	206016000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	203817000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	91187000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	98817000	usd
CY2023Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	114829000	usd
CY2022Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	105000000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	206016000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	203817000	usd
CY2023	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	-1860000	usd
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	-3457000	usd
CY2023	us-gaap	Interest Paid Net InterestPaidNet	183973000	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	85775000	usd
CY2023	us-gaap	Operating Lease Payments OperatingLeasePayments	14070000	usd
CY2022	us-gaap	Operating Lease Payments OperatingLeasePayments	15696000	usd
CY2023	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	1835000	usd
CY2022	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	4161000	usd
CY2023	oprt	Non Cash Investment In Capitalized Assets NonCashInvestmentInCapitalizedAssets	-305000	usd
CY2022	oprt	Non Cash Investment In Capitalized Assets NonCashInvestmentInCapitalizedAssets	2672000	usd
CY2023	oprt	Other Noncash Financing Activities OtherNoncashFinancingActivities	17807000	usd
CY2022	oprt	Other Noncash Financing Activities OtherNoncashFinancingActivities	1550000	usd
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Use of Estimates ‑</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> The preparation of the consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements, and the reported amounts of income and expenses during the reporting period. These estimates are based on information available as of the date of the consolidated financial statements; therefore, actual results could differ from those estimates and assumptions.</span></div>
CY2023	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Concentration of Credit Risk ‑ </span>Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of loans receivable at fair value.
CY2023Q4	us-gaap	Financing Receivable Threshold Period Past Due FinancingReceivableThresholdPeriodPastDue	P120D
CY2023	oprt	Loans Held For Sale Sale Period From Origination LoansHeldForSaleSalePeriodFromOrigination	P4D
CY2022	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	108500000	usd
CY2023	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
CY2023	us-gaap	Property Plant And Equipment Impairment PropertyPlantAndEquipmentImpairment	<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Impairment ‑ </span>The Company reviews long-lived assets, including fixed assets, right of use assets and system development costs, for impairment whenever events or changes in circumstances indicate that the carrying amount of the assets may not be fully recoverable. An impairment loss is recognized when estimated undiscounted future cash flows expected to result from the use of the asset and its eventual disposition are less than its carrying amount.
CY2022	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0	usd
CY2023	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0	usd
CY2023	us-gaap	Revenue Recognition Interest RevenueRecognitionInterest	<div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Revenue Recognition ‑ </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company’s primary sources of revenue consist of interest and non-interest income. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Interest Income</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Interest income includes interest and fees on loans. Generally, the Company’s loans require semi-monthly or biweekly borrower payments of interest and principal. Fees on loans include billed late fees offset by charged-off fees. The Company charges borrowers a late fee if a scheduled installment payment becomes delinquent. Depending on the loan, late fees are assessed when the loan is <span style="-sec-ix-hidden:f-318">eight</span> to 16 days delinquent. Late fees are recognized when they are billed. When a loan is charged off, uncollected late fees are also written off. For Loans Receivable at Fair Value, interest income includes (i) billed interest and late fees, plus (ii) origination fees recognized at loan disbursement, less (iii) charged-off interest and late fees. Additionally, direct loan origination expenses are recognized in operating expenses as incurred. For Loans Receivable at Fair Value, loan origination fees and costs are recognized when incurred.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Interest income on our personal loans receivable is recognized based upon the amount the Company expects to collect from its borrowers. When a loan becomes delinquent for a period of 90 days or more, interest income continues to be recorded until the loan is charged off. Delinquent loans are charged off at month-end during the month it becomes 120 days’ delinquent. Previously accrued and unpaid interest is also charged off in the month the Company receives a notification of bankruptcy, a judgment or mediated agreement by the court, or loss of life, unless there is evidence that the principal and interest are collectible. </span></div>Interest income on our credit card receivables is recognized on the current balance on the account, inclusive of outstanding principal balance plus previously unpaid interest and fees, at the end of the monthly billing cycle. Delinquent credit card accounts, including unpaid interest and fees are charged off at month-end during the month they become 180 days contractually past due.
CY2023Q4	us-gaap	Financing Receivable Threshold Period Past Due Writeoff FinancingReceivableThresholdPeriodPastDueWriteoff	P120D
CY2022	us-gaap	Stock Issued During Period Shares Treasury Stock Reissued StockIssuedDuringPeriodSharesTreasuryStockReissued	0	shares
CY2023	us-gaap	Treasury Stock Shares Retired TreasuryStockSharesRetired	0	shares
CY2022	us-gaap	Treasury Stock Shares Retired TreasuryStockSharesRetired	0	shares
CY2023	us-gaap	Stock Issued During Period Shares Treasury Stock Reissued StockIssuedDuringPeriodSharesTreasuryStockReissued	0	shares
CY2023	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	6663275	shares
CY2022	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	7874995	shares
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-179951000	usd
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-179951000	usd
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	36875950	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	32825772	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	36875950	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	32825772	shares
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-4.88
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-2.37
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-4.88
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-2.37
CY2023Q4	us-gaap	Capitalized Computer Software Accumulated Amortization CapitalizedComputerSoftwareAccumulatedAmortization	119810000	usd
CY2022Q4	us-gaap	Capitalized Computer Software Accumulated Amortization CapitalizedComputerSoftwareAccumulatedAmortization	79679000	usd
CY2023Q4	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	87267000	usd
CY2022Q4	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	104124000	usd
CY2023	us-gaap	Capitalized Computer Software Additions CapitalizedComputerSoftwareAdditions	31000000	usd
CY2022	us-gaap	Capitalized Computer Software Additions CapitalizedComputerSoftwareAdditions	51500000	usd
CY2023	us-gaap	Capitalized Computer Software Impairments1 CapitalizedComputerSoftwareImpairments1	5600000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	15658000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	8249000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	27468000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	35677000	usd
CY2023	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	7700000	usd
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	7900000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	7538000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	4929000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	4929000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	4929000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	4780000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	0	usd
CY2023Q4	oprt	Finite Lived Intangible Asset Expected Amortization FiniteLivedIntangibleAssetExpectedAmortization	27105000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	48944000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	48212000	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	41953000	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	37688000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	6991000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	10524000	usd
CY2023Q4	us-gaap	Prepaid Expense Current And Noncurrent PrepaidExpenseCurrentAndNoncurrent	15758000	usd
CY2022Q4	us-gaap	Prepaid Expense Current And Noncurrent PrepaidExpenseCurrentAndNoncurrent	24167000	usd
CY2023Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	48123000	usd
CY2022Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	1793000	usd
CY2023Q4	us-gaap	Income Tax Receivable IncomeTaxReceivable	4731000	usd
CY2022Q4	us-gaap	Income Tax Receivable IncomeTaxReceivable	8245000	usd
CY2023Q4	oprt	Receivable From Banking Partner ReceivableFromBankingPartner	4050000	usd
CY2022Q4	oprt	Receivable From Banking Partner ReceivableFromBankingPartner	2878000	usd
CY2023Q4	us-gaap	Derivative Assets DerivativeAssets	9307000	usd
CY2022Q4	us-gaap	Derivative Assets DerivativeAssets	725000	usd
CY2023Q4	us-gaap	Other Assets Miscellaneous OtherAssetsMiscellaneous	18720000	usd
CY2022Q4	us-gaap	Other Assets Miscellaneous OtherAssetsMiscellaneous	15848000	usd
CY2023Q4	us-gaap	Other Assets OtherAssets	107680000	usd
CY2022Q4	us-gaap	Other Assets OtherAssets	64180000	usd
CY2023	us-gaap	Depreciation Depreciation	4300000	usd
CY2022	us-gaap	Depreciation Depreciation	5200000	usd
CY2023Q4	us-gaap	Line Of Credit Facility Maximum Borrowing Capacity LineOfCreditFacilityMaximumBorrowingCapacity	700000000	usd
CY2023Q4	us-gaap	Warehouse Agreement Borrowings WarehouseAgreementBorrowings	289951000	usd
CY2022Q4	us-gaap	Warehouse Agreement Borrowings WarehouseAgreementBorrowings	317568000	usd
CY2023Q4	oprt	Secured Debt At Amortized Cost SecuredDebtAtAmortizedCost	581468000	usd
CY2023Q4	us-gaap	Accounts Payable Current And Noncurrent AccountsPayableCurrentAndNoncurrent	5288000	usd
CY2022Q4	us-gaap	Accounts Payable Current And Noncurrent AccountsPayableCurrentAndNoncurrent	9670000	usd
CY2023Q4	us-gaap	Employee Related Liabilities Current And Noncurrent EmployeeRelatedLiabilitiesCurrentAndNoncurrent	15359000	usd
CY2022Q4	us-gaap	Employee Related Liabilities Current And Noncurrent EmployeeRelatedLiabilitiesCurrentAndNoncurrent	12502000	usd
CY2023Q4	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	24791000	usd
CY2022Q4	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	26193000	usd
CY2023Q4	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	8415000	usd
CY2022Q4	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	8445000	usd
CY2023Q4	us-gaap	Servicing Liability At Amortized Value Balance ServicingLiabilityAtAmortizedValueBalance	4169000	usd
CY2022Q4	us-gaap	Servicing Liability At Amortized Value Balance ServicingLiabilityAtAmortizedValueBalance	3073000	usd
CY2023Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	0	usd
CY2022Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	30575000	usd
CY2023Q4	oprt	Current Tax Liabilities Net CurrentTaxLiabilitiesNet	7139000	usd
CY2022Q4	oprt	Current Tax Liabilities Net CurrentTaxLiabilitiesNet	5912000	usd
CY2023Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	3777000	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	3658000	usd
CY2023Q4	us-gaap	Other Liabilities OtherLiabilities	68938000	usd
CY2022Q4	us-gaap	Other Liabilities OtherLiabilities	100028000	usd
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	100000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	100000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1000000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1000000000	shares
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	34741076	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	34469053	shares
CY2023Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	272023	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	33626630	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	33354607	shares
CY2022Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	272023	shares
CY2023Q4	oprt	Number Of Stockholder Approved Plan NumberOfStockholderApprovedPlan	1	plan
	us-gaap	Stock Issued During Period Shares Employee Stock Purchase Plans StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans	0	shares
CY2023	oprt	Employee Stock Ownership Plan Esop Number Of Additional Shares Authorized EmployeeStockOwnershipPlanESOPNumberOfAdditionalSharesAuthorized	333546	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Maximum Employee Subscription Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate	0.15
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Purchase Price Of Common Stock Percent SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent	0.85
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Purchase Price Of Common Stock Percent SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent	0.85
CY2023	oprt	Share Based Compensation Arrangement By Share Based Payment Award Options Exercise Period Upon Termination ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisePeriodUponTermination	P3M
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	3298538	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	17.71
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y5M4D
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	202000	usd
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	16210	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	5.78
CY2023	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	182214	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	4.41
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	467333	shares
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	20.16
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	106048	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	14.74
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2559153	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	18.25
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P4Y3M21D
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	0	usd
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	2559153	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	18.25
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P4Y3M21D
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	0	usd
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	2226861	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	18.80
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P3Y10M20D
CY2023Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	0	usd
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	3.85
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	7.76
CY2023	oprt	Proceeds Payments From Stock Options Exercised ProceedsPaymentsFromStockOptionsExercised	-46000	usd
CY2022	oprt	Proceeds Payments From Stock Options Exercised ProceedsPaymentsFromStockOptionsExercised	-4636000	usd
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	268000	usd
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	11884000	usd
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	3500000	usd
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	3863000	usd
CY2023	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	800000	usd
CY2022	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	1600000	usd
CY2023	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	800000	usd
CY2022	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	6200000	usd
CY2023	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	18593000	usd
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	27620000	usd
CY2023	us-gaap	Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount	1400000	usd
CY2022	us-gaap	Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount	2500000	usd
CY2023	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	5100000	usd
CY2022	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	8100000	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount	3500000	usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount	3300000	usd
CY2023	us-gaap	Defined Contribution Plan Employer Matching Contribution Percent DefinedContributionPlanEmployerMatchingContributionPercent	0.04
CY2023	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	6200000	usd
CY2022	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	6400000	usd
CY2023	oprt	Interest Income Loans Consumer InterestIncomeLoansConsumer	945118000	usd
CY2022	oprt	Interest Income Loans Consumer InterestIncomeLoansConsumer	854245000	usd
CY2023	oprt	Fee Income Loans Consumer FeeIncomeLoansConsumer	18378000	usd
CY2022	oprt	Fee Income Loans Consumer FeeIncomeLoansConsumer	21869000	usd
CY2023	us-gaap	Interest And Fee Income Loans Consumer InterestAndFeeIncomeLoansConsumer	963496000	usd
CY2022	us-gaap	Interest And Fee Income Loans Consumer InterestAndFeeIncomeLoansConsumer	876114000	usd
CY2023	us-gaap	Gain Loss On Sale Of Notes Receivable GainLossOnSaleOfNotesReceivable	8455000	usd
CY2022	us-gaap	Gain Loss On Sale Of Notes Receivable GainLossOnSaleOfNotesReceivable	5703000	usd
CY2023	us-gaap	Contractually Specified Servicing Fees Amount ContractuallySpecifiedServicingFeesAmount	14685000	usd
CY2022	us-gaap	Contractually Specified Servicing Fees Amount ContractuallySpecifiedServicingFeesAmount	19928000	usd
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	25569000	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	31186000	usd
CY2023	oprt	Interest On Members Accounts InterestOnMembersAccounts	21075000	usd
CY2022	oprt	Interest On Members Accounts InterestOnMembersAccounts	3840000	usd
CY2023	us-gaap	Other Income OtherIncome	23639000	usd
CY2022	us-gaap	Other Income OtherIncome	15774000	usd
CY2023	us-gaap	Noninterest Income Other Operating Income NoninterestIncomeOtherOperatingIncome	93423000	usd
CY2022	us-gaap	Noninterest Income Other Operating Income NoninterestIncomeOtherOperatingIncome	76431000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-261620000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-83793000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	7967000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	8507000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-253653000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-75286000	usd
CY2023	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	200000	usd
CY2022	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	-1217000	usd
CY2023	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	260000	usd
CY2022	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	1505000	usd
CY2023	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	2743000	usd
CY2022	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	2227000	usd
CY2023	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	3203000	usd
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	2515000	usd
CY2023	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-52885000	usd
CY2022	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-712000	usd
CY2023	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-23553000	usd
CY2022	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	806000	usd
CY2023	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-467000	usd
CY2022	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-151000	usd
CY2023	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	-76905000	usd
CY2022	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	-57000	usd
CY2023	us-gaap	Federal Income Tax Expense Benefit Continuing Operations FederalIncomeTaxExpenseBenefitContinuingOperations	-73702000	usd
CY2022	us-gaap	Federal Income Tax Expense Benefit Continuing Operations FederalIncomeTaxExpenseBenefitContinuingOperations	2458000	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-73700000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2500000	usd
CY2023	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.291
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.033
CY2023	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-53267000	usd
CY2022	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-15810000	usd
CY2023	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-19209000	usd
CY2022	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	1403000	usd
CY2023	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	603000	usd
CY2022	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	289000	usd
CY2023	us-gaap	Income Tax Reconciliation Tax Credits IncomeTaxReconciliationTaxCredits	3030000	usd
CY2022	us-gaap	Income Tax Reconciliation Tax Credits IncomeTaxReconciliationTaxCredits	2621000	usd
CY2023	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	2870000	usd
CY2022	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	506000	usd
CY2023	us-gaap	Income Tax Reconciliation Tax Contingencies IncomeTaxReconciliationTaxContingencies	3038000	usd
CY2022	us-gaap	Income Tax Reconciliation Tax Contingencies IncomeTaxReconciliationTaxContingencies	1326000	usd
CY2023	oprt	Effective Income Tax Rate Reconciliation Return To Provision Adjustment EffectiveIncomeTaxRateReconciliationReturnToProvisionAdjustment	-5674000	usd
CY2022	oprt	Effective Income Tax Rate Reconciliation Return To Provision Adjustment EffectiveIncomeTaxRateReconciliationReturnToProvisionAdjustment	-5798000	usd
CY2023	us-gaap	Income Tax Reconciliation Nondeductible Expense Impairment Losses IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses	0	usd
CY2022	us-gaap	Income Tax Reconciliation Nondeductible Expense Impairment Losses IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses	22779000	usd
CY2023	oprt	Income Tax Reconciliation Fines And Penalties IncomeTaxReconciliationFinesAndPenalties	14000	usd
CY2022	oprt	Income Tax Reconciliation Fines And Penalties IncomeTaxReconciliationFinesAndPenalties	578000	usd
CY2023	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	953000	usd
CY2022	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	-194000	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-73702000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2458000	usd
CY2023	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.291
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.033
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	68677000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	41169000	usd
CY2023Q4	oprt	Deferred Tax Assets Rightof Use Assets DeferredTaxAssetsRightofUseAssets	7494000	usd
CY2022Q4	oprt	Deferred Tax Assets Rightof Use Assets DeferredTaxAssetsRightofUseAssets	10174000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	6618000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	8335000	usd
CY2023Q4	oprt	Deferred Tax Asset Capitalized Software DeferredTaxAssetCapitalizedSoftware	5619000	usd
CY2022Q4	oprt	Deferred Tax Asset Capitalized Software DeferredTaxAssetCapitalizedSoftware	0	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals	3032000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals	3361000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	972000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	245000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	92412000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	63284000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	0	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	0	usd
CY2023Q4	oprt	Deferred Tax Liabilities Fair Value Adjustment Bonds Payable DeferredTaxLiabilitiesFairValueAdjustmentBondsPayable	24930000	usd
CY2022Q4	oprt	Deferred Tax Liabilities Fair Value Adjustment Bonds Payable DeferredTaxLiabilitiesFairValueAdjustmentBondsPayable	53210000	usd
CY2023Q4	oprt	Deferred Tax Liabilities Fair Value Adjustments Loans Receivable DeferredTaxLiabilitiesFairValueAdjustmentsLoansReceivable	7095000	usd
CY2022Q4	oprt	Deferred Tax Liabilities Fair Value Adjustments Loans Receivable DeferredTaxLiabilitiesFairValueAdjustmentsLoansReceivable	12077000	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities Leasing Arrangements DeferredTaxLiabilitiesLeasingArrangements	5574000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Leasing Arrangements DeferredTaxLiabilitiesLeasingArrangements	8163000	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	4232000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	6813000	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities Derivatives DeferredTaxLiabilitiesDerivatives	2458000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Derivatives DeferredTaxLiabilitiesDerivatives	0	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities Deferred Expense Capitalized Software DeferredTaxLiabilitiesDeferredExpenseCapitalizedSoftware	0	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Deferred Expense Capitalized Software DeferredTaxLiabilitiesDeferredExpenseCapitalizedSoftware	11803000	usd
CY2023Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	44289000	usd
CY2022Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	92066000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	48123000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	28782000	usd
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	6608000	usd
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	5170000	usd
CY2023	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	1146000	usd
CY2022	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	894000	usd
CY2023	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	1844000	usd
CY2022	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	544000	usd
CY2023	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	950000	usd
CY2022	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	0	usd
CY2023Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	8648000	usd
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	6608000	usd
CY2023	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	1200000	usd
CY2022	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	900000	usd
CY2022	us-gaap	Income Tax Examination Penalties And Interest Expense IncomeTaxExaminationPenaltiesAndInterestExpense	300000	usd
CY2023	us-gaap	Income Tax Examination Penalties And Interest Expense IncomeTaxExaminationPenaltiesAndInterestExpense	300000	usd
CY2023Q4	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	6800000	usd
CY2023Q4	us-gaap	Principal Amount Outstanding Of Loans Held In Portfolio PrincipalAmountOutstandingOfLoansHeldInPortfolio	2935487000	usd
CY2023Q4	oprt	Loansand Leases Receivable Grossat Fair Value LoansandLeasesReceivableGrossatFairValue	2962352000	usd
CY2022Q4	us-gaap	Principal Amount Outstanding Of Loans Held In Portfolio PrincipalAmountOutstandingOfLoansHeldInPortfolio	3130405000	usd
CY2022Q4	oprt	Loansand Leases Receivable Grossat Fair Value LoansandLeasesReceivableGrossatFairValue	3175449000	usd
CY2023Q4	us-gaap	Secured Debt SecuredDebt	1874406000	usd
CY2023Q4	oprt	Secured Debt Fair Value SecuredDebtFairValue	1780005000	usd
CY2022Q4	us-gaap	Secured Debt SecuredDebt	2582025000	usd
CY2022Q4	oprt	Secured Debt Fair Value SecuredDebtFairValue	2387674000	usd
CY2023Q4	us-gaap	Derivative Assets DerivativeAssets	9300000	usd
CY2023Q4	oprt	Derivative Underlying Cash Flows DerivativeUnderlyingCashFlows	12200000	usd
CY2022Q4	oprt	Derivative Underlying Cash Flows DerivativeUnderlyingCashFlows	0	usd
CY2023Q4	us-gaap	Fair Value Option Loans Held As Assets90 Days Or More Past Due FairValueOptionLoansHeldAsAssets90DaysOrMorePastDue	5200000	usd
CY2023Q4	oprt	Fair Value Option Principal Balanceof Loans Heldas Assets90 Daysor More Past Due FairValueOptionPrincipalBalanceofLoansHeldasAssets90DaysorMorePastDue	41500000	usd
CY2022Q4	us-gaap	Fair Value Option Loans Held As Assets90 Days Or More Past Due FairValueOptionLoansHeldAsAssets90DaysOrMorePastDue	4100000	usd
CY2022Q4	oprt	Fair Value Option Principal Balanceof Loans Heldas Assets90 Daysor More Past Due FairValueOptionPrincipalBalanceofLoansHeldasAssets90DaysorMorePastDue	35200000	usd
CY2023	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis Unobservable Inputs Reconciliation Transfers Out Of Level3 FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationTransfersOutOfLevel3	0	usd
CY2023	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis Unobservable Inputs Reconciliation Transfers Into Level3 FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationTransfersIntoLevel3	0	usd
CY2022	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis Unobservable Inputs Reconciliation Transfers Out Of Level3 FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationTransfersOutOfLevel3	0	usd
CY2022	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis Unobservable Inputs Reconciliation Transfers Into Level3 FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationTransfersIntoLevel3	0	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	12786000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	10851000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	4700000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	1661000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	435000	usd
CY2023Q4	oprt	Lessee Operating Lease Liability To Be Paid Year Six LesseeOperatingLeaseLiabilityToBePaidYearSix	40000	usd
CY2023Q4	oprt	Lessee Operating Lease Liability To Be Paid After Year Six LesseeOperatingLeaseLiabilityToBePaidAfterYearSix	0	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	30473000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	2097000	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	28376000	usd
CY2023Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P2Y8M12D
CY2023Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0472
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	13879000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	11940000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	9969000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	3918000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	1032000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	25000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	40763000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	2816000	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	37947000	usd
CY2022Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P3Y2M12D
CY2022Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0406
CY2023	us-gaap	Operating Lease Expense OperatingLeaseExpense	17400000	usd
CY2022	us-gaap	Operating Lease Expense OperatingLeaseExpense	18500000	usd
CY2023Q4	us-gaap	Purchase Obligation Due In Next Twelve Months PurchaseObligationDueInNextTwelveMonths	44800000	usd
CY2023Q4	us-gaap	Purchase Obligation Due In Second Year PurchaseObligationDueInSecondYear	26500000	usd
CY2023Q4	us-gaap	Purchase Obligation Due In Third Year PurchaseObligationDueInThirdYear	3300000	usd
CY2023Q4	us-gaap	Purchase Obligation Due In Fourth Year PurchaseObligationDueInFourthYear	1000000	usd
CY2023Q4	us-gaap	Purchase Obligation Due After Fifth Year PurchaseObligationDueAfterFifthYear	0	usd
CY2022Q1	oprt	Minimum Loan Sale Rate Whole Loan Sale Program MinimumLoanSaleRateWholeLoanSaleProgram	0.10
CY2022Q1	oprt	Incremental Optional Loan Sale Rate Whole Loan Sale Program IncrementalOptionalLoanSaleRateWholeLoanSaleProgram	0.05
CY2022Q4	oprt	Loan Sale Commitment Minimum Whole Loan Sale Program LoanSaleCommitmentMinimumWholeLoanSaleProgram	2000000	usd
CY2022Q4	oprt	Loan Sale Commitment Option Additional Sale Whole Loan Sale Program LoanSaleCommitmentOptionAdditionalSaleWholeLoanSaleProgram	4000000	usd
CY2022Q4	oprt	Loan Sale Commitment Option Additional Sale Period Whole Loan Sale Program LoanSaleCommitmentOptionAdditionalSalePeriodWholeLoanSaleProgram	P1Y
CY2023Q4	us-gaap	Other Commitment OtherCommitment	32900000	usd
CY2022Q4	us-gaap	Other Commitment OtherCommitment	45000000	usd
CY2023Q1	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Each Warrant Or Right ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight	4193453	shares
CY2023Q1	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.01

Files In Submission

Name	View Source	Status
0001538716-24-000032-index-headers.html	Edgar Link	pending
0001538716-24-000032-index.html	Edgar Link	pending
0001538716-24-000032.txt	Edgar Link	pending
0001538716-24-000032-xbrl.zip	Edgar Link	pending
ceocertificationexyearend2.htm	Edgar Link	pending
cfocertificationexyearend2.htm	Edgar Link	pending
consentofaccountingfirmyea.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
image.jpg	Edgar Link	pending
image_0a.jpg	Edgar Link	pending
image_0b.jpg	Edgar Link	pending
image_1.jpg	Edgar Link	pending
image_101.jpg	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
image_102.jpg	Edgar Link	pending
image_103.jpg	Edgar Link	pending
image_104.jpg	Edgar Link	pending
image_11.jpg	Edgar Link	pending
image_13.jpg	Edgar Link	pending
image_14.jpg	Edgar Link	pending
image_168.jpg	Edgar Link	pending
image_169.jpg	Edgar Link	pending
image_1a.jpg	Edgar Link	pending
image_1b.jpg	Edgar Link	pending
image_2.jpg	Edgar Link	pending
image_2a.jpg	Edgar Link	pending
image_3.jpg	Edgar Link	pending
image_3a.jpg	Edgar Link	pending
image_4.jpg	Edgar Link	pending
image_5.jpg	Edgar Link	pending
image_6.jpg	Edgar Link	pending
image_8.jpg	Edgar Link	pending
image_92.jpg	Edgar Link	pending
image_94.jpg	Edgar Link	pending
image_95.jpg	Edgar Link	pending
image_96.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
oportun-rlsa.htm	Edgar Link	pending
oportunccw-fifthamendmentt.htm	Edgar Link	pending
oportunccw-masteramendment.htm	Edgar Link	pending
oportunccw-seventhamendmen.htm	Edgar Link	pending
oportundescriptionofcapita.htm	Edgar Link	pending
oportunrf-seventhamendment.htm	Edgar Link	pending
oportunrf-sixthamendmentto.htm	Edgar Link	pending
oprt-20231231.htm	Edgar Link	pending
oprt-20231231.xsd	Edgar Link	pending
oprt-20231231_g1.jpg	Edgar Link	pending
oprt-20231231_g2.jpg	Edgar Link	pending
oprtcompensationrecoverypo.htm	Edgar Link	pending
oprtinsidertradingpolicy.htm	Edgar Link	pending
oprtlistofsubsidiaries.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
oprt-20231231_def.xml	Edgar Link	unprocessable
oprt-20231231_lab.xml	Edgar Link	unprocessable
oprt-20231231_pre.xml	Edgar Link	unprocessable
oprt-20231231_htm.xml	Edgar Link	completed
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
section1350certificationex.htm	Edgar Link	pending
Show.js	Edgar Link	pending
oprt-20231231_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$OPRT
Oportun Financial Corp Stock $oprt

2024 Q1 Form 10-K Financial Statement

#000153871624000032 Filed on March 15, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$OPRT Oportun Financial Corp Stock $oprt

2024 Q1 Form 10-K Financial Statement

#000153871624000032 Filed on March 15, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$OPRT
Oportun Financial Corp Stock $oprt